Cerenome (CNSY) Return on Equity [ROE] (2011 - 2026)
Cerenome's Return on Equity [ROE] came in at -299.45% for Q2 2026, down 66.41 percentage points from the prior quarter.
Powered by 
Analysis
Cerenome (CNSY) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2023, Cerenome's Return on Equity [ROE] was -522.50%, down 287.84 percentage points from FY2022.
- Return on Equity [ROE] carries a five-year change of -383.86 percentage points (FY2018 to FY2023).
- Going back by year, Return on Equity [ROE] was -234.66% in FY2022 (-41.33 pp), -193.34% in FY2021 (+199.93 pp), -393.27% in FY2020 (-52.25 pp) and -341.02% in FY2019 (-202.37 pp).
- The five-year range for quarterly Return on Equity [ROE] is -2090.42% (Q4 2023) to -96.14% (Q3 2021).
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2021 (a gain of 186.85 percentage points), and the weakest in Q4 2023 (a drop of 1863.23 percentage points).
- Business Quant data shows CNSY's Return on Equity [ROE] at -233.04% (Q1 2026), -347.62% (Q4 2025) and -344.21% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Cerenome | 13.67 Mn | -33.51 Mn | - | -299.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -299.45% |
| Mar 31, 2026 | -233.04% |
| Dec 31, 2025 | -347.62% |
| Sep 30, 2025 | -344.21% |
| Dec 31, 2023 | -2,090.42% |
| Sep 30, 2023 | -572.14% |
| Jun 30, 2023 | -642.30% |
| Mar 31, 2023 | -459.64% |
| Dec 31, 2022 | -227.19% |
| Sep 30, 2022 | -178.56% |
| Jun 30, 2022 | -142.29% |
| Mar 31, 2022 | -116.19% |
| Dec 31, 2021 | -104.76% |
| Sep 30, 2021 | -96.14% |
| Jun 30, 2021 | -101.01% |
| Mar 31, 2021 | -157.46% |
| Dec 31, 2020 | -291.61% |
| Sep 30, 2020 | -127.34% |
| Jun 30, 2020 | -89.57% |
| Mar 31, 2020 | -1,417.51% |
API Access
Cerenome Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CNSY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CNSY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CNSY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();